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slightly down regulate cyclin B1 in umbilical 
vein endothelial cells (Park et al., 2002).  
Curcumin Research center has found some 
candidates of curcumin analogues which 
has the potency of anticancer. 
Pentagamavunon-1 (PGV-1) is one of 
the curcumin analogues which showed to 
have potency in inhibiting proliferation of 
T47D human breast carcinoma cell. The 
previous research found that PGV-1 at the 
concentration of 2.5 mM modulates cell cycle 
progression through G2/M arrest, followed 
by hyperploidy of the cell and mitotic 
catarstrophe on T47D cells (Dai et al., 2007). In 
this effect, PGV-1 induces p21 expression 
and CDK-1 dephosphorilation. PGV-1 may 
interact with tubulin leading to the 
inhibition of microtubule polymerization as 
indicated by occurrence of tubulin 
condensation. However the cells may 
undergo mitosis but it is not followed by 
cytokinesis resulting in the hyperploidy. 
Introduction
Curcumin is  one of the major 
components of turmeric, a phytochemical 
agent which contains chemopreventive 
properties against tumors. Many medicinal 
properties of curcumin are well recognized. 
Curcumin has been shown to inhibit 
proliferation of a wide variety of tumour 
cells. The incubation of T47D breast cancer 
cells with 10 mM curcumin for 24 hours 
induced G1 accummulation  cell population 
(Da’i et al, 2007).  Curcumin was found to 
induce G0/G1 and/or G2/M arrest, 
upregulated CDKIs, p21, p27, p53 and 
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        Carcinogenesis may resulted from the malfunctioning of programmed cell death. Most of the anticancer drugs in 
current use induce apoptosis in susceptible cells. The fact that disparate agent interacting with different targets seem 
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of inhibiting cell growth. Pentagamavunon-1 (PGV-1) is one of the curcumin analogues which showed to have 
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These findings suggest that PGV-1 may act 
as microtubule inhibitor and can be 
categorized as an anti-microtubule agent.
The objective of this research was to 
observe the mechanisms of PGV-1 as 
antimicrotubule drug which may interact 




T47D cell line was kindly provided by 
Division of Genetic Function in Animal 
laboratory, NAIST, Japan. Cells were  
maintained  in DMEM (Sigma) plus 10% 
fetal bovine serum (Thermo Sci) and 1% 
penicillin/streptomycin. 
Flowcytometric analysis
5 T47D cells  were seeded at 5 x 10  
cells/well on six wells tissue culture plate.  
After 24 hours incubation, cells were treated 
with 2.5 mM PGV-1 and 1 mM Taxol and 
incubated for 6, 12 and 24 hours. Cells were 
collected by trypsinized, spin at 1000 rpm for 
3 minutes and washed twice with cold PBS. 
Cells were resuspended in propidium 
iodide solution (50 mg/ml in PBS contained 
1% triton X-100)  and then treated with 
RNAse DNAse free (20 mg/ml) for 10 
0minutes at 37 C. The treated cells then 
subjected to Facscalybour flowcytometry. 
Cell cycle profiles were analysed using cell 
quest acquisition program.
Immunofluorescence microscopy
T47D cells were grown on glass 
4coverslip at 2.5 X 10  cells/well. After 24 
hours incubation cells on coverslip were 
treated with 2.5 mM PGV-1 and 1 mM taxol 
and incubated  for 12 hours and 24 hours. 
Cells on coverslip were fixed with 4% 
paraformaldehyde in PBS for 10 minutes at 
room temperature and permeabilized with 
0.1% triton X-100 in PBS for 5 minutes. After 
blocking in 1% bovine serum albumine in 
PBS for 60 minutes, cells were incubated in 
primary antibody against  a-tubulin (1:200) 
for 1 hour and washed with PBS to remove 
unbound antibody. Then cells were 
incubated with anti mouse IgG FITC 
conjugated secondary antibody (1:100) for 1 
hour. Nuclear morphology were observed 
by staining with DAPI (0.1 mg/ml). cells on 
coverslip were mounted on permafluor 
mounting and observed on fluorescence 
mycroscope.
Microtubule polymerization assay 
T47D cells were seeded on 60 mm dish at 
58 x 10  cells/dish. After 24 hours incubation 
cells were treated with 2 mg/ml of 
nocodazol for 2 hours to depolymerize 
tubulin. Cells then released from nocodazol 
and lysed at 0, 4, 8 and 12 minutes in 400 ml 
of microtubule stabilizing lysis buffer 
containing 4 mM paclitaxel or 4 mM PGV-1, 
0.1 M PIPES pH 6.9, 2 M glycerol, 5mM 
MgCl , 2 mM EGTA, 0.5% triton x-100, 5 2
mg/ml leupeptin. Cell lysate were 
centrifugated at 25.000 rpm for 30 minutes at 
022 C for sedimentation of polymeric tubulin. 
The sediment (containing polymeric 
tubulin) was subjected to 150 ml 
solubilization buffer containing 25 mM Tris-
HCl pH 7.5, 0.4 M NaCl, 1% NP-40, 0.5% 
SDS, 0.1% deoxycholate, 5 mg/ml leupeptin. 
The resulting sample were analyzed on 
western blot using a-tubulin antibody
Results 
The Effect PGV-1 on cell cycle progression 
of cancer cell
Flowcytometric analysis was used to 
observe the distribution of cell population 
on cell cycle. As shown in figure 1, there was 
an accumulation at G2/M phase of T47D 
cells treated with 2.5 mM PGV-1 and 1 mM 
taxol after 12 hours incubation. After 24 
hours incubation, PGV-1 treated cells PGV-1 
showed  an increase in polyploidy (M5) and 
decrease in sub G1 phase. The cells treated 
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with 1 mM taxol showed an increasing in 
cells with polyploidy DNA content and 
decreasing in sub G1.
P G V - 1  i n h i b i t s  t u b u l i n  
polymerization
To observe microtubule interaction 
effect of PGV-1, it was important to observe 
the polymerization mechanism on PGV-1 
treated cells. Nocodazole, a tubulin-
depolymerizing agent was used to 
transiently deploymerize tubulin in cells, 
followed by releasing in complete medium 
without nocodazole. Tubulin staining in the 
cells were determined by fluorescent 
microscopy and tubulin polymerization 
were determined by western blot analysis.  
Tubulin staining showed  that cells without 
treatment exhibit characteristic pattern of 
individual microtubule as indicated by a fine 
network mesh of microtubular material and 
nuclei of these control were intact as 
visualized by staining with Dapi. Cells 
treated with PGV-1 showed a slightly fine 
network mesh, microtubule disruption and 
multinuclei. Cells treated with taxol showed 
tubulin condensation distinctly and 
condensed chromatin (Figure 2).  Tubulin 
polymerization assay displayed that taxol 
treated cells indicated an accumulation of 
polymerized tubulin starting at 4 minutes 
after releasing nocodazole and then striking 
accumulation at 12 minutes after releasing 
nocodazole. In contrast, cells treated with 
PGV-1 showed a decreasing accumulation of 
polymerized tubulin at 0, 4, 8 and 12 
respectively after releasing nocodazole 
(Figure 3). This findings suggest that PGV-1 
and taxol may interact with tubulin in 
different mechanism.
Fig 2.  Tubulin polymerization effect of PGV-1. 
Microtubule were stained with green-FITC conjugated 
a-tubulin antibody, DNA were stained with DAPI and 
observed on fluorescent microscope.
Fig 3. Tubulin polymerization efect of PGV-1 by 
western blot analysis. T47D cells were treated with 
ocodazole to depolymerize microtubule and released 
at 0, 4, 8, 12 minutes, and lysed with buffer containing 4 
mM PGV-1 or taxol
Discussion. 
Pentagamavunon-1 (PGV-1) is  one of 
curcumin analogues which has the potency 
of inhibiting cell proliferation. Its IC 50 on 
T47D cells is 1.5 mM and 2.5 mM on MCF-7 
cells which is lower than curcumin (20 mM) 
(Da’i et al, 2007).
The data showed that PGV-1 induced 
Figure 1. Flowcytometric analysis. Cells were treated 
with 2.5 mM PGV-1 and 1 mM Taxol, incubated for 12 
and 24 hours, and stained with propidium iodide. 
T47D cells shown an accumulation on G2/M phase. 
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ce l l  cyc le  a r res t  in  G2/M phase  
significantlyat 2.5 mM concentration which 
was followed by hyperploidy of the cells and 
seemed to induce mitotic catarstrophe. The 
previous study showed that PGV-1 induced 
p21 expression and cdc-2 activation (Da’1, 
2007). Activation of cdc-2 may cause cell 
accumulation at hiperploidi area (M5) in 
flowcytometric analysis.  A compound 
which has the potency of inducing G2/M 
arrest  followed by hiperploidi, cdc-2 and 
p21 activation  indicates the characteristic of 
antimicrotubule agent (Okada and Mak, 
2004, Wang et al, 2000). 
Microtubule is a major component of the 
mi to t i c  sp indle ,  which  pul l s  the  
chromosome apart at mitosis and then splits 
the dividing cell into two.  The majority of 
antimitotic agents induce mitotic arrest by 
interacting with tubulin (Zhang et al, 2006). 
Several antimitotic agent have been reported 
to induce P53 and inhibit cyclin-dependent 
kinase, p21 and activate/inactivate several 
protein kinase including raf/Ras, mitogen 
activated protein kinase and p34cdc2. The 
previous study on PGV-1 showed that PGV-
1 induced apoptosis by p53-independent 
apoptosis in T47D cells (Da’i et al, 2007).
 The data on mycroscopic analysis  
indicated that PGV-1 disrupt microtubule 
assembly.  Cell treated with taxol  showed a 
distinct microtubule condensation and 
condensed chromatin. This finding 
indicated  that PGV-1 had different 
mechanism from taxol in interacting with 
tubul in .  Taxo l  s tab i l i zed  tubul in  
polymerization while PGV-1 inhibit tubulin 
polymerization. However, the antimitotic 
effect of PGV-1 need to be confirmed further 
by  fact that the treatment of cells with this 
compound triggered several molecular 
event involved in mitotic signaling cascade. 
This includes of some important mitotic 
regulatory proteins such as Bcl2, cdc25C and 
cyclin B accumulation.
As the conclusion of this research, PGV-
1 modulates cell cycle progression through 
G2/M arrest  and inhibits  tubulin 
polymerization. PGV-1 can be categorized as 
antimitotic agent.
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